Compugen Net Cash Flow from Operations from 2010 to 2024

CGEN Stock  USD 2.58  0.04  1.57%   
Check Compugen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compugen main balance sheet or income statement drivers, such as Depreciation And Amortization of 452.2 K, Interest Expense of 29.4 K or Selling General Administrative of 6.6 M, as well as many exotic indicators such as Price To Sales Ratio of 4.98, Dividend Yield of 0.0 or Operating Cycle of 702. Compugen financial statements analysis is a perfect complement when working with Compugen Valuation or Volatility modules.
  
This module can also supplement Compugen's financial leverage analysis and stock options assessment as well as various Compugen Technical models . Check out the analysis of Compugen Correlation against competitors.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

About Compugen Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Compugen income statement, its balance sheet, and the statement of cash flows. Compugen investors use historical funamental indicators, such as Compugen's Net Cash Flow from Operations, to determine how well the company is positioned to perform in the future. Although Compugen investors may use each financial statement separately, they are all related. The changes in Compugen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Compugen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Compugen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Compugen. Please read more on our technical analysis and fundamental analysis pages.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. Compugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Compugen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Compugen's short interest history, or implied volatility extrapolated from Compugen options trading.

Pair Trading with Compugen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Compugen Stock

  0.67A Agilent Technologies Earnings Call TodayPairCorr

Moving against Compugen Stock

  0.87MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.86VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.84KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.77ME 23Andme HoldingPairCorr
  0.76MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Compugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugen to buy it.
The correlation of Compugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out the analysis of Compugen Correlation against competitors.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
Note that the Compugen information on this page should be used as a complementary analysis to other Compugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Compugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.21)
Revenue Per Share
0.382
Quarterly Revenue Growth
3.461
Return On Assets
(0.08)
Return On Equity
(0.26)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.